The ETP Nanomedicine, an initiative led by industry and set up together with the European Commission is addressing the application of nanotechnology to achieve breakthroughs in healthcare.
Nanomedicine exploits the improved and often novel physical, chemical and biological properties of materials at the nanometer scale. Nanomedicine has the potential to enable early detection and prevention, and to essentially improve diagnosis, treatment and follow-up of diseases.
The ETP supports its members in coordinating their joint research efforts and improving communication amongst the members as well as towards the European Commission and the European Member States.
The EU-funded consortium ENATRANS (Enabling Nanomedicine TRANSlation) launches the first Translation Advisory Board (TAB), a new instrument to provide free of charge advice and support to ambitious international Nanomedicine projects. The call is open to companies, academics and private researchers in Europe promoting Nanomedicine projects. First-in-class recognized experts from industry will deliver concrete and invaluable advice to drive selected Nanomedicine projects into innovative products for healthcare. Among those ambitious projects, the most promising will benefit from further high value services such as in-depth advice, showcase and coaching…(To apply this call, refer to the Flyer).
Deadline : 1st cut-off date for TAB applications is extended to September 21th, 2015
About the ENATRANS project
Enabling NAnomedicine TRANSlation, a Coordination and Support Action funded by the European Commission, has been built to help the translation of innovative projects related to Nanomedicine to successfully go through the different stages of development from the idea to the patients and also improve global knowledge on Nanomedicine. ENATRANS is led by a consortium of 7 partners belonging to the European Technology Platform for Nanomedicine (ETPN): CEA-LETI (Grenoble, France), Nanobiotix SA (Paris, France), Gesellschaft fur Bioanalytik Muenster e.V. (Muenster, Germany), Tel-Aviv University (Tel-Aviv, Israel), Fondazione Don Carlo Gnocchi ONLUS (Milan, Italy), TecMinho (Braga, Portugal) and VDI/VDE-IT (Berlin, Germany).